Mitokinin Inc Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Mitokinin Inc is a biotechnology research company developing small molecule therapeutics that selectively increase the activity of the active-form PINK1 without disturbing endogenous regulation. PINK1 is a master regulator of mitochondrial quality control, and mutations in PINK1 are linked to familial Parkinson's disease, making mitochondrial dysfunction a key target in neurodegenerative disease research. The company emphasizes disease-modifying approaches to neurodegenerative conditions and operates with a team including neuroscientists, chemists, pharmacologists, and administrative staff.

Based in San Francisco, California, Mitokinin maintains a focused program aimed at activating PINK1 to address mitochondrial dysfunction in neurodegenerative disease. A recent development highlighting early collaboration is the integration with X-Chem, which signals alignment of chemistry with Mitokinin's biological discoveries.

Sign up for free to view info

Company overview Employee directory